6 news items
Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software
SLP
15 May 24
pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
SLP
4 Apr 24
is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
SLP
3 Apr 24
, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide
Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date
SLP
20 Mar 24
, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
SLP
13 Mar 24
pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology
xw8bg9wp9omiwjmztmf6uylqvovlefv9wlxntxul0fhrlnb 4j66r26g
SLP
5 Mar 24
pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major
- Prev
- 1
- Next